Recent cytogenetic and molecular studies with highly polymorphic microsatellite markers have implicated allele loss involving chromosome 4 in several human cancers, which suggests the presence of multiple tumor suppressor gene (TSG) loci. However, there has been no detailed analysis of loss of heterozygosity (LOH) on chromosome 4 in oral squamous cell carcinoma (OSCC). To determine the location of a putative TSG associated with OSCC on chromosome 4, polymerase chain reaction (PCR) analysis of microsatellite polymorphisms corresponding to 17 loci was performed to screen 32 patients with OSCC. LOH was observed in the majority of the tumors (75%) in at least one of the loci. The loci on the long arm exhibited a signi®cantly higher frequency of deletions (66%) than those of the short arm (25%). Among the loci tested, frequent LOH was centered at D4S1573 on 4q25, which represents a region of about 4 centimorgans (cM). However, no commonly deleted regions were found on the short arm of the chromosome. We detected microsatellite instability (MI) in 31% of the cases. MI was also observed more frequently on the long arm (28%) than the short arm (6%). Thus, our data indicate that alterations of chromosome 4 regions, especially the long arm, are associated with OSCC tumorigenesis and that the 4q25 region may harbor at least one putative TSG.
Keywords: chromosome 4; loss of heterozygosity (LOH); oral carcinoma; tumor suppressor gene (TSG) Oral squamous cell carcinoma (OSCC) is the most common malignant disease of the oral and maxillofacial region, and the sixth most frequent cancer worldwide (Parkin et al., 1993) . However, little is known about the molecular basis of OSCC compared to other human malignancies. Activation of oncogenes and inactivation of tumor suppressor genes (TSGs) are considered to be associated with carcinogenesis, and alterations in TSGs are widely accepted to be critical events in the multistep process leading to the development of cancer. Loss of heterozygosity (LOH) in malignant cells has proven useful for mapping DNA regions potentially harboring candidate TSGs (Weinberg, 1991) . These genes are thought to encode proteins that negatively regulate cell growth and thus suppress tumorigenesis. Studies based on somatic LOH have already led to the discovery of several TSGs, such as the retinoblastoma (Rb) gene, adenomatous polyposis coli (APC) gene (Marshall, 1991) , and fragile histidine triad (FHIT) gene (Ohta et al., 1996) . In OSCC, we have observed high frequencies of LOH on chromosome 11q (Uzawa et al., 1996) , 5q (Wang et al., 1997) and 7q (Wang et al., 1998) and several regions harboring candidate TSGs were also identi®ed.
LOH in head and neck squamous cell carcinoma (HNSCC), including some OSCCs, has been described for a number of chromosomes, and detailed studies show that 3p, 5q, 9p, 11p, 11q, 13q and 17p exhibit frequent deletions (Ah-See et al., 1994; Nawroz et al., 1994; Van Dyke et al., 1994; Uzawa et al., 1996; ElNaggar et al., 1995) . Allelic imbalances were also reported on chromosome 4 in a number of human solid neoplasms, such as cancers of cervix Larson et al., 1996; Mitra et al., 1994) , bladder (Polascik et al., 1995; Elder et al., 1994) , esophagus (Hammoud et al., 1996) , liver (Chou et al., 1998; Leon and Kew, 1996) and head and neck (Pershouse et al., 1997) . However, little has been done to study the involvement of chromosome 4 in OSCCs using LOH screening. In this report, to investigate the frequency of deletions on chromosome 4 in OSCCs, a set of 17 highly polymorphic markers was used to screen LOH at loci on both the long and short arms of the chromosome. We examined 70 tissue samples (32 sets of primary and normal tissues and six metastatic specimens) from 32 patients with various grades of OSCC. All cases showed heterozygous genotypes in normal tissues at one or more loci on this chromosome. The patterns of allelic imbalance on chromosome 4 in tumor samples are summarized in Figure 1 . Physical mapping positions are based on the previously published human genetic map of chromosome 4 (Gyapay et al., 1994) . All (except #25), of the tumors with allelic imbalance on 4q involved at least one area at 4q25. The deletions of DNA sequences on chromosome 4 were interstitial in most of these tumor samples. No homozygous deletions were found by comparative multiplex PCR analysis which was described by Shridhar et al. (1997) . Representative autoradiographs of the markers D4S404 and D4S1611 illustrating LOH, and D4S404 and D4S406 illustrating MI are shown in Figure 2 . The majority of tumors (24 of 32, 75%) showed LOH. The frequency of deletions on the long arm (4q) and short arm (4p) of chromosome 4 were 66% (21 of 32) and 25% (eight of 32), respectively. 4q showed a signi®cantly higher incidence of deletions than that of 4p (P=0.001). MI was also observed more frequently at 4q (nine of 32, 28%) than 4p (two of 32, 6%), the dierence being statistically signi®cant (P=0.02). These results are in agreement with the results of Pershouse et al. (1997) , indicating that the alterations on chromosome 4q play an important role in the genesis of OSCC. Detailed clinicopathologic data for each case showing LOH and/or MI are summarized in Table 1 . Five tumor samples exhibited no LOH or MI of chromosome 4 loci (tumors #1, 3, 12, 18 and 19) . Seventeen tumor specimens contained alterations only on 4q while two cases had alterations restricted to the short arm of the chromosome.
We found a commonly deleted region at 4q25, where the most frequent allelic losses were also detected by Pershouse et al. (1997) in HNSCC. These ®ndings suggest that 4q25 is a candidate region harboring at least one TSG associated with the genesis of oral carcinomas. Having studied 27 cases of HNSCC, which included 16 OSCCs, Pershouse et al. (1997) observed two regions of common deletion: (1) a large area involving the centromeric region of the short arm, (2) a region of about 7 cM showing complex alterations that involved an area at 4q25 from the markers D4S1571 to D4S1573. However, in our results no commonly deleted region was found on the short arm of chromosome 4. On the long arm the common region of loss was centered at D4S1573 on 4q25 (48%, 10/21), which is approximately 4 cM based upon the Genethon map of chromosome 4 (Gyapay et al., 1994) . The discrepancies could be attributed to either a sampling bias (types of tumors studied, patient population dierences) or dierent technical and interpretive approaches. In this study, the incidence of MI at D4S1573 was also higher than other loci, indicating that LOH may also re¯ect the genomic instability of OSCCs.
We compared our results with the clinicopathologic features of the tumors. A number of sites displaying LOH at chromosome 4 could be detected in early stage lesions, and the frequencies of LOH tended to be higher in later clinical stages. However, no statistically signi®cant correlation was found between the presence of LOH and clinical stage of the tumors in the present study. These results indicate that the inactivation of the (Gyapay et al., 1994) . The minimal region with the most common deletion are boxed. The frequencies of LOH in OSCC for each locus are listed. LOH, number of tumor that showed allelic loss at each marker. Inf, number of informative samples Figure 2 Examples of deletion and instability in microsatellite loci on chromosome 4 in OSCC specimens. Case numbers are shown above and locus symbols below. N, paired normal tissue; T, tumor tissue. LOH is observed in #28 and #21. MI are shown in #30 and #2 putative TSG(s) is an early event in OSCC, as lower stage tumors have a similar frequency of LOH as more advanced cases. There was also a tendency of moderately and poorly dierentiated tumors to have a higher incidence of LOH, but no signi®cant statistical correlation was found. Furthermore, we failed to observe any relationship between the number of deletions per specimen and the grade of differentiation. MI was present at multiple loci in 10/32 (31%) of the tumors, but again no apparent association between the incidence of MI and histopathologic grading or clinical stage was noted in our study. DNAs from the metastatic tissues of six patients were also analysed. Four cases of LOH and two cases of MI were observed. However, as our sample size was small, we were unable to demonstrate a statistically signi®cant dierence between the metastatic and non-metastatic tumors.
In conclusion, the higher frequency of allele losses at the D4S1573 locus suggests that at least one putative TSG is located within 4 cM¯anking the 4q25 region, and its inactivation is a common event and may occur at an early stage of oral tumor progression. Gingiva   IV  II  IV  IV  I  I  III  IV  I  II  IV  IV  IV  III  IV  III  I  III  IV  IV  IV  III  III  IV  IV  II 
